Navigation Links
International Federation-Lilly Agreement Will Allow Significant Increase in MDR-TB Programmes
Date:11/29/2007

TB programmes include providing patients with care, food and support, educating the community about the spread and symptoms of tuberculosis, detecting new cases through surveillance, and addressing the stigma associated with the disease. In addition, cured patients are often recruited as Red Cross and Red Crescent volunteers and provide invaluable psychological support to current patients. According to the World Health Organisation (WHO), community-based TB care significantly improves both access to services and adherence to treatment.

The WHO global TB control report for 2007 confirms progress has been made in recent years to control the TB pandemic, which kills 1.6 million people each year. But much more needs to be done. The European region, for example, has the highest level of TB treatment failures, and as a result, 15 percent of all new TB cases in the Baltic States, Eastern Europe and Central Asia are multidrug-resistant, a rate that is three times higher than in any other region in the world.

Currently, Red Cross and Red Crescent Societies in more than 20 countries address the needs of some 20,000 clients with TB and MDR-TB among the most vulnerable and marginalised groups in society - including the very poor, the homeless, the elderly, prisoners, and substance abusers. Many are also HIV- positive, and because of their weakened immune system, are at particular risk of dying from TB. To address this situation, many Red Cross and Red Crescent Societies are integrating their TB and HIV programmes, particularly in Asia (such as Myanmar) and in Africa (such as Kenya, Mozambique, South Africa and Zimbabwe).

The International Federation is an active partner in the Global Stop TB Partnership, whose aim is to decrease the prevalence and death rates of TB by 50 per cent by 2015.

(*) Tuberculosis is a very contagious disease, which spreads through the air. If not treated, every person with active TB infects, on average, 10 to 15 people each
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... in a phase 1/2 clinical trial that it ... patients newly diagnosed with multiple myeloma, a cancer of ... Dana-Farber Cancer Institute. , Partial responses or better were ... the drug combination in the multi-center study, with 74 ... the phase 2 population, reports Paul G. Richardson, MD, ...
(Date:12/5/2009)... Is Most Challenging-- ,, PHILADELPHIA and NEW ... genes, dubbed partner genes, that fuse with another gene ... By more accurately defining specific partner genes, researchers expect ... treatments. ,, Oncologists also aim to use this ...
(Date:12/5/2009)... and test their cleaning processes. The technology available to the lab ... problems for customers relating to cleaning parts, process development, and verification. ... ... Inc , a Jackson, MI-based company, is home to an advanced ...
(Date:12/4/2009)... PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: ... Directors has set the regular 2010 Annual Meeting of Stockholders ... 16, 2009. The meeting will be held at the Crowne ... at 4:30 p.m. PT. ,, The meeting will be webcast ...
(Date:12/4/2009)... 4 Allied World Assurance,Company Holdings, Ltd (NYSE: ... Chief Executive Officer, and Jack Sennott, Executive Vice,President and ... 2009,Goldman Sachs U.S. Financial Services Conference being held at ... Tuesday, December 8, 2009. ,, ...
Breaking Medicine News(10 mins):Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
... sugar-sweetened soft drinks may increase a woman’s risk of developing ... women between ages 26 and 46 for eight years. At ... diabetes or any other serious illnesses. Results show women who ... and were nearly twice as likely to develop type 2 ...
... a new study offer a ray of hope for patients ... // involved in research on the drug Tarceva, trying ... cancer. ,Tarceva is a small molecule designed to ... known as EGFR, which is critical to cell growth in ...
... may be what you need say researchers. In a recent ... vegetables which may reduce the risk of ischemic strokes, ... cut off oxygen supply to the brain. Carotenoids are the ... researchers measured the levels in blood samples of nearly 22,000 ...
... capacity to regenerate following exercise or injury and harbors two ... satellite cells and adult stem cells // that can be ... these stem cells is involved in muscle tissue repair, but ... injury. ,In previous studies, researchers have demonstrated that Pax7 ...
... in the United States, about 35,000 people will be diagnosed ... test gets closer to an earlier and more// accurate diagnosis., ... be kidney cancer. Currently, the only way to detect kidney ... resonance imaging, but Frozzitta's tests showed uncertain results., ,"Seventy ...
... about 444,000 people in the United States each year. On ... years, while women // who smoke cut their life expectancy ... of smoking. ,In 1964, the Surgeon General’s Report ... larynx in men and chronic bronchitis in both men and ...
Other Medicine News:Health News:Regeneration of muscle 2Health News:Urine Test for Kidney Cancer 2
(Date:12/6/2009)... FDA has approved new technology that now allows ... The SonoCine Automated Whole-breast Ultrasound Method and is ... - Arizona Breastnet, in Scottsdale. This unique technology ... tool to enhance yearly mammography screening. Until now, ... - not for screening for breast cancer. ,, ...
(Date:12/6/2009)... -- RNL Bio Co., Ltd, ( www.rnl.co.kr ) ... cell therapeutics announced today that a 46-year-old female, ... receiving stem cell treatment. Park was suffering from ... the central nervous system (brain and spinal cord). ... which the nerves of the central nervous system ...
(Date:12/4/2009)... 4 A new, $2.8 million, four-year federal grant ... of Medicine and their collaborators at Wake Forest University ... blood degrades over time and how to address the ... been associated with increased risk for cardiovascular events and ...
Breaking Medicine Technology:New FDA Approved Breast Cancer Screening Tool 2New FDA Approved Breast Cancer Screening Tool 3Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3New Option for Erasing Wrinkles 47913 1New Option for Erasing Wrinkles 47913 2New Option for Erasing Wrinkles 47913 3New Option for Erasing Wrinkles 47913 4LNA Based HIF 1 Alpha Inhibitor Shows Early Signs of Clinical Benefit 12470 1LNA Based HIF 1 Alpha Inhibitor Shows Early Signs of Clinical Benefit 12470 2LNA Based HIF 1 Alpha Inhibitor Shows Early Signs of Clinical Benefit 12470 3Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 1Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 2Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 3Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 4Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 5Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 6Cantel Medical Reports a 109 25 Increase in Net Income EPS of 240 25 vs 240 12 for Quarter Ended April 30 2009 47909 7
... after the identification of,the gene responsible for progeria, ... team of Spanish and French researchers (Carlos,Lopez-Otin and ... Levy and coll. -,Inserm/AP-HM, Marseille, France) have successfully ... treatment, combining two existing,pharmacological molecules, should slow down ...
... the, Anti-Tumor Activity of Bavituximab in Combination with Carboplatin and ... ... Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that patient screening,and dosing ... efficacy of bavituximab in combination with chemotherapy in patients,with non-small cell lung ...
Other Medicine Technology:Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4
... for temporary internal drainage ... to the bladder. Supplied ... Intended for one-time use. ... advised; C-Flex® and Sof-Flex® ...
Used to introduce Cook-Cope loop and other catheters for percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: